These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15836002)

  • 1. EMEA: for patients or for industry?
    Garattini S
    Pharmacoeconomics; 2005; 23(3):207-8. PubMed ID: 15836002
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry concern over EU hepatotoxicity guidance.
    Hughes B
    Nat Rev Drug Discov; 2008 Sep; 7(9):719. PubMed ID: 19172685
    [No Abstract]   [Full Text] [Related]  

  • 3. European Medicines Agency pledges to publish clinical reports.
    Watson R
    BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699
    [No Abstract]   [Full Text] [Related]  

  • 4. New drug approval success rate in Europe in 2009.
    Eichler HG; Aronsson B; Abadie E; Salmonson T
    Nat Rev Drug Discov; 2010 May; 9(5):355-6. PubMed ID: 20431561
    [No Abstract]   [Full Text] [Related]  

  • 5. EMA's reflection on placebo does not reflect patients' interests.
    Bertele' V; Banzi R; Gluud C; Garattini S
    Eur J Clin Pharmacol; 2012 May; 68(5):877-9. PubMed ID: 22134525
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients mutiny against Orphan Drug Act.
    Margolid RE
    Healthspan; 1992 Feb; 9(2):25-6. PubMed ID: 10117860
    [No Abstract]   [Full Text] [Related]  

  • 7. International Health Research after Schrems v. Data Protection Commissioner.
    Rothstein MA
    Hastings Cent Rep; 2016; 46(2):5-6. PubMed ID: 26659840
    [No Abstract]   [Full Text] [Related]  

  • 8. EMEA approves OGS drug rejected by FDA.
    Mitchell P
    Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug trade bodies rally patient groups to deflect calls for full trial data.
    O'Dowd A
    BMJ; 2013 Jul; 347():f4702. PubMed ID: 23882001
    [No Abstract]   [Full Text] [Related]  

  • 10. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 11. Can advocates keep congress focused on HIV?
    AIDS Alert; 2001 Dec; 16(12):157-8. PubMed ID: 11768874
    [No Abstract]   [Full Text] [Related]  

  • 12. The European Medicines Agency is still too close to industry.
    Garattini S
    BMJ; 2016 May; 353():i2412. PubMed ID: 27154140
    [No Abstract]   [Full Text] [Related]  

  • 13. The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.
    Milton MN; Horvath CJ
    Toxicol Pathol; 2009 Apr; 37(3):363-71. PubMed ID: 19246571
    [No Abstract]   [Full Text] [Related]  

  • 14. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Medicines Agency tightens rules on conflict of interest.
    Cohen D
    BMJ; 2010 Oct; 341():c5902. PubMed ID: 20959306
    [No Abstract]   [Full Text] [Related]  

  • 16. [The European Union in favor of children].
    Fàbrega C; Pozas M
    Farm Hosp; 2006; 30(4):209-10. PubMed ID: 17022713
    [No Abstract]   [Full Text] [Related]  

  • 17. Senate proposal would reduce drug prices for federal agencies.
    Weissenstein E
    Mod Healthc; 1992 Aug; 22(33):20. PubMed ID: 10119805
    [No Abstract]   [Full Text] [Related]  

  • 18. Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents.
    Doshi P
    JAMA Intern Med; 2013 Nov; 173(21):2009-11. PubMed ID: 23959623
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines regulation and the pharmaceutical industry.
    Breckenridge A; Woods K
    BMJ; 2005 Oct; 331(7520):834-6. PubMed ID: 16210285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EU health ministers reject proposal for limited direct to consumer advertising.
    Watson R
    BMJ; 2003 Jun; 326(7402):1284. PubMed ID: 12805139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.